MYM Nutraceuticals to Build One of World's Largest Greenhouse Cannabis Growing Facilities in Weedon, Quebec
The Weedon agreement was signed by a subsidiary of MYM, CannaCanada Inc., a Montréal-based cannabis company that MYM has purchased 75% of. By the completion of the project, MYM will own 90% of CannaCanada Inc. CannaCanada’s strong ties with Weedon city officials allowed MYM to also obtain full exclusivity regarding the future development of any cannabis or hemp-growing facilities within the municipality.
The municipality of Weedon, which is approximately two hours east of Montréal, is actively involved in the project. Weedon has already identified the land on which the facility will be built and has signed an option to purchase it. The subject to certain requirements, Weedon will exercise that option and then donate the land to the project.
MYM anticipates that the project will advance quickly as Weedon’s planning department has already approved the preliminary construction designs for the initial portion of the facility. The detailed plans for the first 100,000-sq-ft greenhouse and a 20,000-sq-ft warehouse are now being drawn up by the MYM’s architects, Latimer Hu. MYM has engaged Factotum Consultants, who have successfully obtained two Licensed Producer licenses for other clients to manage the ACMPR application process and expects to submit its application to Health Canada this Friday.
“This is an important and significant deal for MYM and its shareholders,” said Rob Gietl, MYM’s CEO. “The sheer scope and exclusivity of this project will bring MYM global attention and propel the company into its next stage of growth. We have all of the architects, engineers, and consultants in place, and with the full support of the municipality of Weedon, we are moving ahead at an accelerated pace.”
MYM has committed to manage and fund the project and will pay $75,000 and issue 250,000 common shares to CannaCanada or its principles, with a further 250,000 shares six months later. When the project’s ACMPR application reaches pre-license inspection stage, MYM will issue CannaCanada or its principles an additional 500,000 shares. When the application is approved by Health Canada and a license is granted, MYM will issue a further 1,000,000 shares, and another 1,000,000 shares one year later. In exchange for these milestones, MYM’s ownership of the project will grow from 75% initially, to 85% when the license is granted, then to 90% one year later. MYM will also pay a 10% finder’s fee, in common shares, to the person who brought the deal to management’s attention.
Yann Lafleur, the President of CannaCanada Inc. commented, “CannaCanada’s bond with the municipality of Weedon, Quebec will create sustainability that will reflect on the entire industry of cannabis leading to incredible future projects involving many other aspects of the industry. MYM Nutraceuticals will supply us with the necessary resources and tools in order to establish this deed and transmit this heritage. Creating an alliance with MYM Nutraceuticals enables our enterprise to expand into the U.S. and European territories in order to spread this wealth of information and experience for generations to come. MYM Nutraceuticals and their entire team will be a divine asset to establishing a patrimony of cannabis in this country. Our joined network of leading cannabis experts will pave the way to the continuity of results, remaining leaders in this new industry.”
MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE: MYM) (OTC: MYMMF) (FRA: 0MY) (DEU: 0MY) (MUN: 0MY) (STU: 0MY).
ON BEHALF OF THE BOARD
MYM Nutraceuticals Inc. http://www.mymarijuana.ca
This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on http://www.sedar.com.
This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States“, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.
Click here to connect with MYM Nutraceuticals Inc. (CSE:MYM) to receive an Investor Presentation.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).